Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma

Glioblastoma multiforme (GBM) is the most common and aggressive primary intracranial brain tumor in adults with a mean survival of 14 to 15 months. Aberrant activation of the epidermal growth factor receptor (EGFR) plays a significant role in GBM progression, with amplification or overexpression of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hicks, Martin J., Chiuchiolo, Maria J., Ballon, Douglas, Dyke, Jonathan P., Aronowitz, Eric, Funato, Kosuke, Tabar, Viviane, Havlicek, David, Fan, Fan, Sondhi, Dolan, Kaminsky, Stephen M., Crystal, Ronald G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053413/
https://www.ncbi.nlm.nih.gov/pubmed/27711187
http://dx.doi.org/10.1371/journal.pone.0162978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053413/
https://www.ncbi.nlm.nih.gov/pubmed/27711187
http://dx.doi.org/10.1371/journal.pone.0162978

Ejemplares similares